GM Pastores

664 total citations
14 papers, 487 citations indexed

About

GM Pastores is a scholar working on Physiology, Epidemiology and Organic Chemistry. According to data from OpenAlex, GM Pastores has authored 14 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 7 papers in Epidemiology and 6 papers in Organic Chemistry. Recurrent topics in GM Pastores's work include Lysosomal Storage Disorders Research (13 papers), Trypanosoma species research and implications (6 papers) and Carbohydrate Chemistry and Synthesis (6 papers). GM Pastores is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Trypanosoma species research and implications (6 papers) and Carbohydrate Chemistry and Synthesis (6 papers). GM Pastores collaborates with scholars based in United States, Norway and Spain. GM Pastores's co-authors include Grabowski Ga, Jennifer Angell, J. A. Barranger, Seymour Packman, Albert Miller, R J Desnick, Barry E. Rosenbloom, Neal J. Weinreb, Henry J. Mankin and Ramnik J. Xavier and has published in prestigious journals such as Blood, Neuroscience and Nephrology Dialysis Transplantation.

In The Last Decade

GM Pastores

14 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
GM Pastores United States	9	427	213	154	153	137	14	487
Dyane Auclair Australia	10	339 0.8×	155 0.7×	53 0.3×	75 0.5×	60 0.4×	13	385
Cordula Steglich Germany	16	609 1.4×	358 1.7×	158 1.0×	132 0.9×	226 1.6×	24	805
Alessandra Zanetti Italy	13	337 0.8×	165 0.8×	57 0.4×	87 0.6×	109 0.8×	22	419
C. Martini Italy	9	252 0.6×	87 0.4×	54 0.4×	135 0.9×	80 0.6×	12	358
Emory Ryan United States	9	332 0.8×	74 0.3×	93 0.6×	218 1.4×	123 0.9×	23	383
Maria Prociuk United States	8	286 0.7×	79 0.4×	83 0.5×	72 0.5×	112 0.8×	10	396
Therese Ruane United States	7	294 0.7×	96 0.5×	51 0.3×	78 0.5×	176 1.3×	11	510
Orit Neudorfer Israel	7	397 0.9×	73 0.3×	70 0.5×	256 1.7×	117 0.9×	9	583
WS Sly United States	7	323 0.8×	118 0.6×	53 0.3×	84 0.5×	115 0.8×	9	461
Robert McGlynn United States	5	245 0.6×	72 0.3×	56 0.4×	107 0.7×	74 0.5×	6	333

Countries citing papers authored by GM Pastores

Since Specialization

Citations

This map shows the geographic impact of GM Pastores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GM Pastores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GM Pastores more than expected).

Fields of papers citing papers by GM Pastores

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GM Pastores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GM Pastores. The network helps show where GM Pastores may publish in the future.

Co-authorship network of co-authors of GM Pastores

This figure shows the co-authorship network connecting the top 25 collaborators of GM Pastores. A scholar is included among the top collaborators of GM Pastores based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GM Pastores. GM Pastores is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Orsini, Joseph J., GM Pastores, Richard Chang, et al.. (2011). Krabbe disease: Clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards. Molecular Genetics and Metabolism. 105(1). 126–131. 20 indexed citations

Pastores, GM, J. A. Barranger, Seymour Packman, et al.. (2008). Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48‐month longitudinal cohort study. Clinical Genetics. 73(5). 430–440. 95 indexed citations

Weinreb, Neal J., J. A. Barranger, Seymour Packman, et al.. (2007). Imiglucerase (Cerezyme^®) improves quality of life in patients with skeletal manifestations of Gaucher disease. Clinical Genetics. 71(6). 576–588. 76 indexed citations

Pastores, GM, et al.. (2007). Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease. Nephrology Dialysis Transplantation. 22(7). 1920–1925. 31 indexed citations

Weinreb, Neal J., GM Pastores, Paul M. Fernhoff, et al.. (2007). Pharmacological Chaperone Therapy for the Treatment of Gaucher Disease: Results of Phase 1 Clinical Trials and a Clinical Ex Vivo Response Study with a Survey of Blood Markers for 53 Gaucher Patients.. Blood. 110(11). 2404–2404. 1 indexed citations

Mankin, H J, et al.. (2006). A questionnaire study for 128 patients with Gaucher disease. Clinical Genetics. 69(3). 209–217. 15 indexed citations

Suresh, Vettath Raghavan, Bai Jin Zeng, Paola Torres, et al.. (2005). Globoid cell leukodystrophy (Krabbe disease): Normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations. Journal of Inherited Metabolic Disease. 28(6). 1005–1009. 7 indexed citations

Pastores, GM. (2004). Agalsidase alfa: enzyme therapy for Anderson–Fabry disease. Therapy. 1(2). 203–211. 2 indexed citations

Miller, Albert, et al.. (2003). Pulmonary involvement in Type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease. Clinical Genetics. 63(5). 368–376. 41 indexed citations

10.

Pérez‐Calvo, Juan Ignacio, et al.. (2003). Extended interval between enzyme therapy infusions for adult patients with Gaucher's disease type 1.. PubMed. 49(2). 127–31. 12 indexed citations

11.

Zeng, Bai Jin, et al.. (2002). Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson’s disease. Neuroscience. 113(3). 629–640. 33 indexed citations

12.

Scott, C. Ronald, GM Pastores, Hanna Andersson, et al.. (2000). The clinical expression of Gaucher disease correlates with genotype: Data from 570 patients. Genetics in Medicine. 2(1). 65–65. 2 indexed citations

13.

Pastores, GM, et al.. (1993). Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood. 82(2). 408–416. 8 indexed citations

14.

Pastores, GM, et al.. (1993). Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood. 82(2). 408–416. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact